AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $889.25
- 52-wk high
- $996.84
- High
- $897.51
- 52-wk low
- $684.98
- Low
- $880.27
- Prev close
- $889.12
- Mkt cap
- $103.96B
- P/E
- 23.9x
- Volume
- 972.4K
- Fwd P/E
- 19.9x
- Beta
- 0.31
- Div yield
- 0.37%
- P/S
- 0.3x
- P/B
- 5.0x
- Profit margin
- +1.1%
- Op margin
- +1.4%
- ROE
- +0.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 5.2% above what analysts expected.
Earnings per share
$9.44 expected
Revenue
$103.74B expected
GAAP EPS was $5.15 and adjusted EPS was $9.93. The adjusted figure is comparable to consensus.
What the street expects next
EPS expected
$10.53 to $11.26
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $103.15B | $106.16B | $96.30B | $105.38B |
| Cost of what it sold | $99.61B | $102.47B | $92.25B | $101.69B |
| Gross profit | $3.54B | $3.69B | $4.04B | $3.69B |
| What it spent | ||||
| Sales and admin | $2.07B | $2.03B | $1.80B | $2.26B |
| Other operating costs | — | $36.0M | — | $102.0M |
| Total operating expenses | $2.07B | $2.07B | $1.80B | $2.37B |
| What was left | ||||
| Operating profit | $1.47B | $1.62B | $2.25B | $1.32B |
| Interest on debt | $74.0M | $63.0M | $61.0M | $77.0M |
| Profit before tax | $1.40B | $1.63B | $2.13B | $1.31B |
| Tax | $232.0M | $380.0M | $270.0M | $276.0M |
| Net profit | $1.11B | $1.19B | $1.68B | $614.0M |
| EBITDA | $1.66B | $1.84B | $2.26B | $1.39B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
BullishSep 8McKesson at wells fargo healthcare conference: growth, deal push
BullishSep 8McKesson Corp's negligence caused a data breach, a new class action lawsuit claims
BearishSep 7McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy
Leans bullishSep 6AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 5A Congress Member Sold Up To $15K In Viasat Stock: Here's What You Need To Know
NeutralSep 5AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 4Cencora (COR) Unveils Cell And Gene Therapy Enablement Service
NeutralSep 4
Macro
32 macro signals shaping MCK right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results